In reference to the earlier intimation dated 18.03.2024, Pursuant to Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Kimia Biosciences has informed that the Company has received the confirmation from its Registrar & Transfer Agent, Beetal Financial Computer Services, regarding the issuance of duplicate share certificates. The details of shareholders are enclosed. Pursuant to SEBI Circular No. SEBI/MIRSD/MIRSD_RTAMB/P/2022/8 dated January 25, 2022; a letter of confirmation will be issued to the securities holder/ claimant upon completion of necessary procedures regarding duplicate share certificates.
The above information is a part of company’s filings submitted to BSE.
